Semaglutide is now on most formularies. It is easy to analyse your own results in the on-line ABCD semaglutide audit tool as shown in the how to do it video tutorial.
Some CCGs are requesting local audit and the tool facilitates this. ABCD encourages everybody in the UK using semaglutide to join the nationwide audit, both for the purpose of entering and analysing their own data, but also contributing to the national database which will facilitate detailed analysis with large numbers.
Forms for handwritten data entry that exactly match the online tool can be downloaded from the semaglutide audit webpage, where you can register for the audit and access the on-line tool. As discussed on this page, the clinical trials with semaglutide suggest that it is more effective than the other GLP-1 receptor agonists that we have to date but there remains much that we don’t know that we could learn from this real world audit.
You do not have to be a member of ABCD to join the audit which is open to all users of semaglutide and local data analysis is an appropriate project for medical students, junior doctors and diabetes specialist nurses.
As we have done with previous audits, all contributors will be acknowledged in all papers and presentations from the audit data and biggest contributors will be offered the possibility of being co-authors.
ABCD looks forward to welcoming you to the audit. For more information please contact the ABCD nationwide audits database administrator, Melissa Cull.
With best wishes on behalf of ABCD
Dr Bob Ryder MD. FRCP.
Clinical lead, ABCD audits of new diabetes therapies and devices
Consultant Diabetologist
City Hospital
Dudley Road
Birmingham B18 7QH
